{
    "title": "Sanofi-AstraZeneca's preventive RSV therapy appears safe- FDA staff",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12165401/US-FDA-staff-flag-no-new-safety-issues-Sanofi-AstraZenecas-preventive-RSV-therapy.html",
    "date": "2023-06-06",
    "keywords": [
        "therapy",
        "staff",
        "rsv",
        "age",
        "respiratory",
        "drug",
        "virus",
        "nirsevimab",
        "approval",
        "disease",
        "june",
        "food",
        "tuesday",
        "sanofi",
        "partner",
        "prevention",
        "antibody",
        "safety",
        "profile",
        "health",
        "committee",
        "meeting",
        "thursday",
        "therapys",
        "marketing",
        "application",
        "fdas",
        "use",
        "pneumonia",
        "imbalance",
        "placebo",
        "access",
        "market",
        "commission",
        "year",
        "analyst",
        "damien",
        "conover",
        "latestage",
        "study",
        "reduction",
        "incidence",
        "care",
        "illness",
        "risk",
        "infection",
        "government",
        "consideration",
        "enrollment",
        "group",
        "reporting",
        "raghav",
        "mahobe",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "shounak",
        "dasgupta",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}